News
NVR's Second-Quarter Earnings Get a Boost From America's Hottest Real Estate Markets
What's that tired phrase when it comes to real estate? Location, location, location. Luckily for homebuilder NVR (NYSE: NVR), the hot housing markets are headed back East into NVR's wheelhouse. Those
New Oriental Education & Tech Grp (ADR) Has Established Undeniable Momentum
In the world of for-profit education, there are two metrics to watch: enrollment figures and how efficiently schools are winning over students. The former is pretty straightforward, while the latter
3 Potential Replacements for Intel Corporation's CEO
In a recent column, I provided just three of the many reasons I believe Intel (NASDAQ: INTC) needs new management.Although I have reason to believe Intel's management problems run deeper than just a
IMAX Stock Has a Lot to Prove on Wednesday
There hasn't been a Hollywood ending for IMAX (NYSE: IMAX) investors. The provider of enhanced theatrical experiences hit a four-year low last week, and the pessimism comes just as IMAX is about to
3 Dividend Stocks That Are Perfect for Retirement
If you're at the point in your investing life where you're adjusting your portfolio from higher-risk growth mode toward a safer asset allocation -- one designed to support you dependably through your
SELECTIRENTE : Activité et résultats du 1er semestre 2017
Evry, le 25 juillet 2017,
Stabilité des loyers
Un taux d'occupation du patrimoine immobilier de plus de 95 %
Le chiffre d'affaires de SELECTIRENTE ressort à 7,4 M€ au 1er semestre 2017, en....
ORCLASS.COM : Précisions suite à des rumeurs infondées sur l'activité et à la forte variation du cours de bourse
OrClass.com, acteur majeur du rachat d'or par Internet en France, a constaté une chute importante du cours suite à des ordres de vente à tout prix et à une faible liquidité.
OrClass.com....
An Exciting New Drug Is in Clinical Trials for Aspreva Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals
An Exciting New Drug Is in Clinical Trials for Aurinia Pharmaceuticals
Richard Glickman was the CEO of Aspreva Pharmaceuticals, which put out CellCept, a drug that treats patient with lupus who develop kidney disease. Glickman has moved on to Aurinia Pharmaceuticals
Facebook, Inc. Might Also Jump Into Smart Speaker Fray
Smart speakers are all the rage right now in tech, so it's not all that surprising that Facebook (NASDAQ: FB) is reportedly looking to enter the space. DIGITIMES reports that Facebook is exploring a
Why Shares of Oracle Have Soared 32% So Far This Year
Shares of database giant Oracle (NYSE: ORCL) have soared 31.7% since the beginning of the year, according to data provided by S&P Global Market Intelligence. The gain was driven by two solid quarterly
HERIGE : CHIFFRE D'AFFAIRES AU 30 JUIN 2017 : 282,1 M EUR
Croissance de l'activité au premier semestre de 3%
(à périmètre comparable)
IFRS – M€
Chiffre d'affaires consolidé
2017(1)
2016 (2) IFRS 5
Var. % 2017 vs 2016 IFRS....
GROUPE PAROT : CHIFFRE D'AFFAIRES DU 1ER SEMESTRE 2017 : 202,7 M EUR EN HAUSSE DE +60,1%
Le Groupe PAROT (code ISIN : FR0013204070 - code mnémonique : ALPAR), acteur français de la mobilité automobile, publie son chiffre d'affaires du 1er semestre de l'exercice....
OENEO : ROBUST ACTIVITY IN THE FIRST QUARTER : Excellent pace for Closures and strong performance from Winemaking
Excellent pace for Closures and strong performance from Winemaking
Turnover (€M)
2016-2017
2017-2018
Change
Change at constant scope and exchange rates
1ST....
HERIGE : TURNOVER AT 30 JUNE 2017: EUR 282.1 MILLION
Growth in activity of 3% in the first half
(like-for-like)
IFRS – € million
Consolidated turnover
2017(1)
2016(2) IFRS 5
Change %
2017 vs 2016 IFRS....
OENEO : ACTIVITE SOLIDE AU 1ER TRIMESTRE : Excellente dynamique en Bouchage et bonne performance en Elevage
Chiffre d'AFFAIRES (M€)
2016-2017
2017-2018
Variation
Var a perimetre et change constants
1ER TRIMESTRE
62,9
64,9
+3,2%
+3,0%
Dont....
ALPHA MOS : Chiffre d'affaires du 1er semestre 2017
En M€ - Normes IFRS
Données non auditées
2017
2016
Variation
Chiffre d'affaires consolidé
2,1
3,8
-44%
Alpha MOS (Euronext Paris - Compartiment C - Code ISIN....
Why 3M Company's Shares Dropped Today
Shares of industrial giant 3M Company (NYSE: MMM) fell as much as 6.1% in early morning trading Tuesday after reporting second-quarter 2017 earnings. And shares didn't recover much by midday, trading
A.S.T. GROUPE : AST GROUPE : Chiffre d'affaires S1 2017 = 73.6 M EUR
Communiqué de presse
A Décines-Charpieu, le 25 juillet 2017
Trajectoire de croissance confirmée :
Chiffre d'affaires 1er semestre 2017 : 73,6 M€ (+20%)
Activité commerciale : +....
Why Interpublic Group of Companies Inc Stock Fell Today
Shares of The Interpublic Group of Companies (NYSE: IPG) were tumbling today after the advertising umbrella company posted a disappointing second-quarter earnings report.As of 11:39 a.m. EDT, the
Why Team, Inc. Stock Just Crashed 28.5%
Shares of Team, Inc. (NYSE: TISI), a provider of industrial quality testing services, fell 30% in early Tuesday trading before clawing back to a 28.5% loss as of 12:35 p.m. EDT.Two news items are
General Motors Profit Falls on Pending Opel Sale
General Motors (NYSE: GM) said that its second-quarter net income fell 42% to $1.66 billion, mostly due to the pending sale and restructuring of its operations in Europe.On a continuing-operations
3 Stocks the Market Is Wrong About
The market can sometimes lose track of companies that are no longer showing signs of growth or are waiting in the wings as they work on their next strategic move -- and sometimes stocks can fall to
Westinghouse Air Brake Technologies Corp Rides Its Latest Acquisition to Higher Revenue
Westinghouse Air Brake Technologies (NYSE: WAB), or Wabtec, continues to feel the impact of its recent acquisition of Faiveley Transport, which is providing a revenue boost while dragging down
Alphabet, Inc. Earnings: 5 Metrics You Shouldn't Overlook
Shares of Alphabet (NASDAQ: GOOG) (NASDAQ: GOOGL) are down several percent today following the tech company's second-quarter earnings report. But don't let the pullback in Alphabet shares fool you